Omalizumab - Response In Patients With Severe Allergic Asthma In A Real Life Setting

被引：0
|
作者：
Zierau, L. [1 ]
Walsted, E. S. [1 ]
Backer, V. [1 ]
机构：
[1] Bispebjerg Hosp, Copenhagen NV, Denmark
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2016年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A6474
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Omalizumab decreases IgE production in patients with severe allergic asthma
    Huebner, Marisa
    Korn, Stephanie
    Jung, Matthias
    Buhl, Roland
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [42] Adherence and effectiveness of omalizumab treatment in severe allergic asthma patients
    Ozseker, Z. F.
    Bulut, I
    Erdenen, F.
    Erdogdu, D.
    Asli, G.
    Ersoy, R.
    Kutlu, A.
    Ozturk, S.
    ALLERGY, 2013, 68 : 363 - 364
  • [43] Effect of omalizumab treatment on allergic comorbidities in patients with severe allergic asthma - real life experience from Czech Anti-IgE Registry
    Hutyrova, Beata
    Bystron, Jaromir
    Chlumsky, Jan
    Kindlova, Dagmar
    Klosova, Jana
    Krcmova, Irena
    Novotna, Bronislava
    Panzner, Petr
    Pohunek, Petr
    Ruzickova-Kirchnerova, Olga
    Sedlak, Vratislav
    Terl, Milan
    Vanik, Petr
    Vasakova, Martina
    Vernerova, Eva
    Zatloukal, Jaromir
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [44] Real-Life Effectiveness of Benralizumab, Mepolizumab and Omalizumab in Severe Allergic Asthma Associated with Nasal Polyps
    Tiotiu, Angelica
    Mendez-Brea, Paula
    Ioan, Iulia
    Romero-Fernandez, Rodrigo
    Oster, Jean Philippe
    Hoang, Thi-cam-tu
    Roux, Pauline
    Ochoa-Gutierrez, Diana Carolina
    Bonniaud, Philippe
    de Blay, Frederic
    Gonzalez-Barcala, Francisco-Javier
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2023, 64 (02) : 179 - 192
  • [45] One year following a real life experience of omalizumab for moderate to severe persistent allergic asthma in Malta
    Gouder, Caroline
    West, Lorna
    Montefort, Stephen
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [46] Real life effectiveness of omalizumab in severe allergic asthma, does the IgE level matter? A Bradford experience
    Jain, Salina
    Saralaya, Dinesh
    Regan, Karen
    Walker, Laura
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [47] Real-life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteria
    Hew, M.
    Gillman, A.
    Sutherland, M.
    Wark, P.
    Bowden, J.
    Guo, M.
    Reddel, H. K.
    Jenkins, C.
    Marks, G. B.
    Thien, F.
    Rimmer, J.
    Katsoulotos, G. P.
    Cook, M.
    Yang, I.
    Katelaris, C.
    Bowler, S.
    Langton, D.
    Wright, C.
    Bint, M.
    Yozghatlian, V.
    Burgess, S.
    Sivakumaran, P.
    Yan, K. Y.
    Kritikos, V.
    Peters, M.
    Baraket, M.
    Aminazad, A.
    Robinson, P.
    Jaffe, A.
    Powell, H.
    Upham, J. W.
    McDonald, V. M.
    Gibson, P. G.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2016, 46 (11): : 1407 - 1415
  • [48] The real-life clinical effects of 52 weeks of omalizumab therapy for severe persistent allergic asthma
    Gouder, Caroline
    West, Lorna Marie
    Montefort, Stephen
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (01) : 36 - 43
  • [49] Add-on omalizumab in children with severe allergic asthma: a 1-year real life survey
    Deschildre, Antoine
    Marguet, Christophe
    Salleron, Julia
    Pin, Isabelle
    Rittie, Jean-Luc
    Derelle, Jocelyne
    Abou Taam, Rola
    Fayon, Mickael
    Brouard, Jacques
    Dubus, Jean Christophe
    Siret, Daniel
    Weiss, Laurence
    Pouessel, Guillaume
    Beghin, Laurent
    Just, Jocelyne
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42 (05) : 1224 - 1233
  • [50] The real-life clinical effects of 52 weeks of omalizumab therapy for severe persistent allergic asthma
    Caroline Gouder
    Lorna Marie West
    Stephen Montefort
    International Journal of Clinical Pharmacy, 2015, 37 : 36 - 43
12345